altogether better

Integrated research compliance solutions to streamline your study

Get a Quote

75% of US-Based Operation Warp Speed  Vaccine Trials Overseen by Advarra IRB, IBC

Webinar: October 27

Racial Diversity in Clinical Trials: Building Trust in Participant Engagement

Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.

Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.

Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more

Our Latest Updates

Discover What’s Happening at Advarra

News

Advarra IRB Chair Luke Gelinas Featured in PRIM&R Blog and Webinar About Complexity in Clinical Trial Design

October 20, 2020

In June, Advarra IRB Chairperson Luke Gelinas was a guest speaker in a PRIM&R webinar called Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. As a…

Oct271 pm ET
Webinar

Racial Diversity in Clinical Trials: Building Trust in Participant Engagement

COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions…

Blog

Q&A – The Must-Haves of FDA and Common Rule Reporting Requirements

October 14, 2020

In a recent webinar, Advarra regulatory experts discussed the must-haves of FDA and Common Rule reporting requirements. They reviewed the basics of what must be reported to whom—and when—for sponsors…

Ready for Research Compliance Solutions That Are Altogether Better?

Get Started